Advisor Group Holdings, Inc. Agenus Inc Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.45 - $17.57 $25,438 - $993,232	-56,530 Reduced 62.9%	33,342 $558,000
Q1 2024 May 10, 2024	BUY	$0.53 - $0.93 $24,445 - $42,894	46,123 Added 105.43%	89,872 $52,000
Q4 2023 Feb 12, 2024	SELL	$0.63 - $1.14 $4,750 - $8,596	-7,541 Reduced 14.7%	43,749 $36,000
Q3 2023 Nov 13, 2023	BUY	$1.12 - $1.88 $5,888 - $9,885	5,258 Added 11.42%	51,290 $57,000
Q2 2023 Aug 10, 2023	BUY	$1.31 - $2.04 $15,066 - $23,462	11,501 Added 33.31%	46,032 $73,000
Q1 2023 May 12, 2023	SELL	$1.45 - $2.95 $2,842 - $5,782	-1,960 Reduced 5.37%	34,531 $52,000
Q4 2022 Feb 10, 2023	SELL	$2.02 - $3.25 $6,415 - $10,322	-3,176 Reduced 8.01%	36,491 $87,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $20,521 - $32,875	10,470 Added 35.86%	39,667 $81,000
Q2 2022 Aug 10, 2022	SELL	$1.3 - $2.64 $2,330 - $4,733	-1,793 Reduced 5.79%	29,197 $56,000
Q1 2022 May 04, 2022	BUY	$2.35 - $3.47 $2,681 - $3,959	1,141 Added 3.82%	30,990 $121,000
Q3 2021 Nov 05, 2021	BUY	$4.98 - $6.63 $16,782 - $22,343	3,370 Added 12.73%	29,849 $158,000
Q2 2021 Aug 02, 2021	SELL	$2.56 - $5.49 $3,996 - $8,569	-1,561 Reduced 5.57%	26,479 $146,000
Q1 2021 May 13, 2021	BUY	$2.69 - $5.25 $19,889 - $38,818	7,394 Added 35.81%	28,040 $77,000
Q4 2020 Feb 10, 2021	SELL	$3.17 - $4.49 $634 - $898	-200 Reduced 0.96%	20,646 $66,000
Q3 2020 Nov 12, 2020	SELL	$2.98 - $5.2 $596 - $1,040	-200 Reduced 0.95%	20,846 $84,000
Q2 2020 Aug 14, 2020	SELL	$2.29 - $4.24 $29 - $55	-13 Reduced 0.06%	21,046 $83,000
Q1 2020 May 18, 2020	BUY	$1.92 - $4.39 $40,433 - $92,449	21,059 New	21,059 $51,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account